Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
22 Julio 2024 - 7:00AM
Route 92 Medical, Inc., a privately held medical technology company
dedicated to improving outcomes for patients undergoing
neurovascular intervention, today announced commercial launch of
the FreeClimb® 88 catheter system comprising the FreeClimb 88
catheter and the Tenzing® 8 delivery catheter, all designed to work
with the Base Camp® sheath. The FDA 510(k) cleared FreeClimb 88
catheter system offers reliable navigation through tortuous anatomy
in the neurovasculature and is available in 125 cm and 132 cm
lengths to provide clinicians with the flexibility they need to
reach their targeted locations.
“Route 92 Medical continues to advance neurovascular
intervention through a suite of solutions designed to work
harmoniously to address acute ischemic stroke,” said Tony Chou, CEO
of Route 92 Medical. “The FreeClimb 88 access catheter system,
powered by Tenzing, addresses the unmet need for effective,
super-bore catheters that can reach the M1 segment of the middle
cerebral artery consistently. Route 92 Medical is dedicated to
giving clinicians new tools to treat their most complex cases.”
The tapered tip of the patented Tenzing 8 delivery catheter
significantly reduces ledge effect and allows the FreeClimb 88
catheter to consistently navigate past the ophthalmic artery and
predictably reach the M1 segment of the middle cerebral artery
(MCA). Tenzing’s soft, tapered tip provides atraumatic tracking in
the neurovasculature, and was designed to reach the targeted
locations without the use of a microcatheter.
“Having a broader set of tools gives clinicians greater
flexibility when treating difficult cases,” said Dr. Ajit Puri,
Professor and Director of Neurointervention and Integrated
Cerebrovascular Program at University of Massachusetts medical
center and Portsmouth Regional Hospital. “The .088" catheter
systems will make procedures easier by minimizing set-up
complexity, providing vessel size matching leading to distal flow
control during the delivery of therapeutic devices, and leveraging
the strengths of the Tenzing product design to improve
navigation.”
Route 92 Medical’s family of FreeClimb and HiPoint® products
simplify endovascular thrombectomy procedures by allowing
clinicians to select the optimal length and size of access or
aspiration catheter for every case. Route 92 Medical’s FreeClimb
and HiPoint products are powered by custom-sized Tenzing delivery
catheters, allowing for rapid and predictable delivery to the
targeted location. The FreeClimb 88 system joins the company’s
growing 88 portfolio, including the Monopoint® system, powered by
the HiPoint 88 and Tenzing 8 catheters, and Base Camp sheath.
For more information about other Route 92 Medical-developed
neurovascular intervention devices, visit
www.route92medical.com/products.
About Route 92 Medical, Inc.
Route 92 Medical is on a mission to improve outcomes for
patients undergoing neurovascular intervention through cutting-edge
engineering and innovative product design. Founded by physicians,
the company collaborates with leading neurovascular clinicians to
solve the biggest challenges in neurointervention and deliver
meaningful, differentiated solutions that promote clinical success.
For more information, visit www.r92m.com or follow the company on
LinkedIn.
Contacts:
For media:
Gwen Gordon
Gwen Gordon PR
Gwen@gwengordonpr.com